# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!


Epithelioid Sarcoma

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-4 of 4 results.
Doxorubicin With Upfront Dexrazoxane Plus Olaratumab for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma
Status: Recruiting
Last Changed: Oct 16, 2018
First Received: Oct 22, 2015
Disease(s): Sarcoma, Soft Tissue, Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Leiomyosarcoma, Liposarcoma, Synovial Sarcoma, Myxofibrosarcoma, Angiosarcoma, Fibrosarcoma, Malignant Peripheral Nerve Sheath Tumor, Epithelioid Sarcoma
Intervention(s): Dexrazoxane, Doxorubicin, Olaratumab
Locations: Washington University School of Medicine, Saint Louis, Missouri, United States
A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma
Status: Recruiting
Last Changed: Jan 17, 2019
First Received: Nov 11, 2015
Disease(s): Malignant Rhabdoid Tumors (MRT), Rhabdoid Tumors of the Kidney (RTK), Atypical Teratoid Rhabdoid Tumors (ATRT), Selected Tumors With Rhabdoid Features, Synovial Sarcoma, INI1-negative Tumors, Malignant Rhabdoid Tumor of Ovary, Renal Medullary Carcinoma, Epithelioid Sarcoma, Poorly Differentiated Chordoma (or Other Chordoma With Sponsor Approval), Any Solid Tumor With an EZH2 GOF Mutation
Intervention(s): Tazemetostat
Locations: University of California San Francisco, San Francisco, California, United States
University of Colorado Denver, Aurora, Colorado, United States
Mayo Clinic - Jacksonville, Jacksonville, Florida, United States
Northwestern Memorial Hospital, Chicago, Illinois, United States
Massachusetts General Hospital - Cancer Center, Boston, Massachusetts, United States
... and 28 other locations.
Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue Sarcoma
Status: Recruiting
Last Changed: Nov 06, 2017
First Received: Feb 14, 2012
Disease(s): Adult Alveolar Soft Part Sarcoma, Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor, Adult Epithelioid Hemangioendothelioma, Adult Epithelioid Sarcoma, Adult Extraskeletal Myxoid Chondrosarcoma, Adult Extraskeletal Osteosarcoma, Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Liposarcoma, Adult Malignant Mesenchymoma, Adult Malignant Peripheral Nerve Sheath Tumor, Adult Rhabdomyosarcoma, Adult Synovial Sarcoma, Adult Undifferentiated Pleomorphic Sarcoma, Malignant Adult Hemangiopericytoma, Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
Intervention(s): Gemcitabine Hydrochloride, Laboratory Biomarker Analysis, Pazopanib Hydrochloride, Placebo
Locations: OHSU Knight Cancer Institute, Portland, Oregon, United States
Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery
Status: Recruiting
Last Changed: May 11, 2018
First Received: Jan 04, 2017
Disease(s): Metastatic Angiosarcoma, Metastatic Epithelioid Sarcoma, Metastatic Fibrosarcoma, Metastatic Leiomyosarcoma, Metastatic Liposarcoma, Metastatic Malignant Peripheral Nerve Sheath Tumor, Metastatic Synovial Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma, Pleomorphic Rhabdomyosarcoma, Stage III Soft Tissue Sarcoma, Stage IV Soft Tissue Sarcoma, Undifferentiated (Embryonal) Sarcoma
Intervention(s): Doxorubicin, Ribociclib
Locations: OHSU Knight Cancer Institute, Portland, Oregon, United States